CO7151477A2 - Material no viable derivado de un probiótico para la prevención y el tratamiento de la infección - Google Patents
Material no viable derivado de un probiótico para la prevención y el tratamiento de la infecciónInfo
- Publication number
- CO7151477A2 CO7151477A2 CO14198811A CO14198811A CO7151477A2 CO 7151477 A2 CO7151477 A2 CO 7151477A2 CO 14198811 A CO14198811 A CO 14198811A CO 14198811 A CO14198811 A CO 14198811A CO 7151477 A2 CO7151477 A2 CO 7151477A2
- Authority
- CO
- Colombia
- Prior art keywords
- probiotic
- prevention
- treatment
- infection
- material derived
- Prior art date
Links
- 208000015181 infectious disease Diseases 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 239000006041 probiotic Substances 0.000 title abstract 2
- 230000000529 probiotic effect Effects 0.000 title abstract 2
- 235000018291 probiotics Nutrition 0.000 title abstract 2
- 239000000463 material Substances 0.000 title 1
- 241001135265 Cronobacter sakazakii Species 0.000 abstract 1
- 230000003698 anagen phase Effects 0.000 abstract 1
- 238000010923 batch production Methods 0.000 abstract 1
- 239000012228 culture supernatant Substances 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nutrition Science (AREA)
- Animal Behavior & Ethology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Pediatric Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Una composición que comprende un sobrenadante del cultivo de una fase de crecimiento exponencial tardío de un proceso por lotes para un probiótico como LGG, para usar en el tratamiento o la prevención de la infección por patógeno C. sakazakii
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12161083 | 2012-03-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO7151477A2 true CO7151477A2 (es) | 2014-12-29 |
Family
ID=48045112
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO14198811A CO7151477A2 (es) | 2012-03-23 | 2014-09-09 | Material no viable derivado de un probiótico para la prevención y el tratamiento de la infección |
Country Status (18)
Country | Link |
---|---|
US (2) | US20130251829A1 (es) |
EP (1) | EP2827725A1 (es) |
CN (2) | CN108714157A (es) |
AR (1) | AR090473A1 (es) |
AU (1) | AU2013235365B2 (es) |
CA (1) | CA2868109A1 (es) |
CO (1) | CO7151477A2 (es) |
EC (1) | ECSP14024082A (es) |
HK (1) | HK1204869A1 (es) |
MX (1) | MX360591B (es) |
MY (1) | MY169754A (es) |
NZ (1) | NZ627915A (es) |
PE (1) | PE20142276A1 (es) |
PH (1) | PH12014502112A1 (es) |
RU (1) | RU2014137188A (es) |
SG (1) | SG11201404378XA (es) |
TW (1) | TWI587864B (es) |
WO (1) | WO2013142403A1 (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130251829A1 (en) * | 2012-03-23 | 2013-09-26 | Mead Johnson Nutrition Company | Probiotic derived non-viable material for infection prevention and treatment |
US20150157048A1 (en) | 2013-12-11 | 2015-06-11 | Mead Johnson Nutrition Company | Nutritional compositions containing stearidonic acid and uses thereof |
US20150290261A1 (en) * | 2014-04-10 | 2015-10-15 | Mead Johnson Nutrition Company | Methods of use for probiotics and prebiotics |
US20150305385A1 (en) | 2014-04-25 | 2015-10-29 | Mead Johnson Nutrition Company | Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics |
US20160029682A1 (en) | 2014-08-01 | 2016-02-04 | Mead Johnson Nutrition Company | Hydrolyzed lactose-containing nutritional compositions and uses thereof |
US20160095339A1 (en) | 2014-10-01 | 2016-04-07 | Mead Johnson Nutrition Company | Nutritional composition for gastrointestinal environment to provide improved microbiome and metabolic profile |
US9730969B2 (en) | 2015-11-06 | 2017-08-15 | Mead Johnson Nutrition Company | Nutritional compositions for promoting gut barrier function and ameliorating visceral pain |
US10034937B2 (en) | 2015-12-04 | 2018-07-31 | Mead Johnson Nutrition Company | Synergistic nutritional compositions and uses thereof |
US20180064739A1 (en) | 2016-09-06 | 2018-03-08 | Mead Johnson Nutrition Company | Nutritional composition with human milk oligosaccharides and uses thereof |
US20180103675A1 (en) | 2016-10-14 | 2018-04-19 | Mead Johnson Nutrition Company | Personalized pediatric nutrition products comprising human milk oligosaccharides |
US20180160714A1 (en) | 2016-12-12 | 2018-06-14 | Mead Johnson Nutrition Company | Nutritional compositions containing butyrate and uses thereof |
US20180161292A1 (en) | 2016-12-12 | 2018-06-14 | Mead Johnson Nutrition Company | Nutritional compositions containing butyrate and uses thereof |
US10980269B2 (en) | 2016-12-12 | 2021-04-20 | Mead Johnson Nutrition Company | Protein hydrolysates and methods of making same |
US20180161381A1 (en) * | 2016-12-12 | 2018-06-14 | Mead Johnson Nutrition Company | Nutritional compositions and methods for reducing the occurrence or severity of viral infections, bacterial infections and viral and bacterial co-infections |
US20180168215A1 (en) | 2016-12-21 | 2018-06-21 | Mead Johnson Nutrition Company | Nutritional compositions containing inositol and uses thereof |
US20180332881A1 (en) | 2017-05-17 | 2018-11-22 | Mead Johnson Nutrition Company | Preterm infant formula containing butyrate and uses thereof |
US20180333426A1 (en) | 2017-05-17 | 2018-11-22 | Mead Johnson Nutrition Company | Nutritional composition with human milk oligosaccharides and uses thereof |
CN107812018A (zh) * | 2017-11-13 | 2018-03-20 | 浙江禾健生营养食品有限公司 | 一种灭活益生菌制品、制备方法及其应用 |
US20190208807A1 (en) | 2018-01-05 | 2019-07-11 | Mead Johnson Nutrition Company | Nutritional compositions containing milk-derived peptides and uses thereof |
GB2573538B (en) | 2018-05-09 | 2023-01-04 | Mjn Us Holdings Llc | Pediatric nutritional compositions and methods for infants delivered by C-section |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4839281A (en) | 1985-04-17 | 1989-06-13 | New England Medical Center Hospitals, Inc. | Lactobacillus strains and methods of selection |
US5407957A (en) | 1990-02-13 | 1995-04-18 | Martek Corporation | Production of docosahexaenoic acid by dinoflagellates |
NZ241359A (en) | 1991-01-24 | 1994-08-26 | Martek Corp | Supplementation of infant formula by the addition of at least two different polyunsaturated fatty acids obtained from at least two different microbial sources; compositions comprising such oils |
US5374567A (en) | 1993-05-20 | 1994-12-20 | The United States Of America As Represented By The Secretary Of The Navy | Operational amplifier using bipolar junction transistors in silicon-on-sapphire |
FI104465B (fi) * | 1995-06-14 | 2000-02-15 | Valio Oy | Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö |
CN1164186C (zh) * | 2001-04-29 | 2004-09-01 | 上海光明乳业股份有限公司 | 益菌奶及其制造方法 |
EP1384483A1 (en) | 2002-07-23 | 2004-01-28 | Nestec S.A. | Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function |
US20040208863A1 (en) * | 2003-01-30 | 2004-10-21 | James Versalovic | Anti-inflammatory activity from lactic acid bacteria |
US7407652B2 (en) * | 2005-06-03 | 2008-08-05 | Aquatechnics Inc. | Probiotic system for aquaculture |
JP2009516738A (ja) * | 2005-11-21 | 2009-04-23 | ティーガスク−ザ アグリカルチャー アンド フード デベロップメント オーソリティー | カゼイン由来の抗菌ペプチドおよびそれを生成するLactobacillus株 |
RU2468807C2 (ru) * | 2007-02-28 | 2012-12-10 | Мед Джонсон Нутришен Компани | Детское питание, содержащее инактивированный пробиотик |
US20080254011A1 (en) * | 2007-04-11 | 2008-10-16 | Peter Rothschild | Use of selected lactic acid bacteria for reducing atherosclerosis |
RU2350648C1 (ru) * | 2007-09-14 | 2009-03-27 | Государственное научное учреждение Научно-исследовательский ветеринарный институт Нечерноземной зоны РФ Российской академии сельскохозяйственных наук | Способ оценки антагонистической активности пробиотиков на основе лиофилизированной биомассы анаэробных бактерий по отношению к патогенным микобактериям |
EP2130440A1 (en) | 2008-06-06 | 2009-12-09 | N.V. Nutricia | Inhibiting E. sakazakii growth |
US8137718B2 (en) * | 2008-09-19 | 2012-03-20 | Mead Johnson Nutrition Company | Probiotic infant products |
EP2295535A1 (en) * | 2009-09-11 | 2011-03-16 | Mead Johnson Nutrition Company | Probiotic material |
US20130251829A1 (en) * | 2012-03-23 | 2013-09-26 | Mead Johnson Nutrition Company | Probiotic derived non-viable material for infection prevention and treatment |
CN104531562B (zh) * | 2014-12-09 | 2018-09-14 | 北京农学院 | 一种植物乳杆菌植物亚种及其抗单增李斯特菌细菌素的制备方法 |
-
2013
- 2013-03-15 US US13/832,828 patent/US20130251829A1/en not_active Abandoned
- 2013-03-18 NZ NZ627915A patent/NZ627915A/en not_active IP Right Cessation
- 2013-03-18 MX MX2014010150A patent/MX360591B/es active IP Right Grant
- 2013-03-18 EP EP13713686.7A patent/EP2827725A1/en not_active Withdrawn
- 2013-03-18 MY MYPI2014702147A patent/MY169754A/en unknown
- 2013-03-18 CA CA2868109A patent/CA2868109A1/en not_active Abandoned
- 2013-03-18 PE PE2014001463A patent/PE20142276A1/es not_active Application Discontinuation
- 2013-03-18 RU RU2014137188A patent/RU2014137188A/ru not_active Application Discontinuation
- 2013-03-18 AU AU2013235365A patent/AU2013235365B2/en not_active Ceased
- 2013-03-18 SG SG11201404378XA patent/SG11201404378XA/en unknown
- 2013-03-18 CN CN201810544250.XA patent/CN108714157A/zh active Pending
- 2013-03-18 CN CN201380015996.7A patent/CN104219968A/zh active Pending
- 2013-03-18 WO PCT/US2013/032757 patent/WO2013142403A1/en active Application Filing
- 2013-03-21 TW TW102110056A patent/TWI587864B/zh not_active IP Right Cessation
- 2013-03-22 AR ARP130100945A patent/AR090473A1/es unknown
-
2014
- 2014-09-09 CO CO14198811A patent/CO7151477A2/es unknown
- 2014-09-23 PH PH12014502112A patent/PH12014502112A1/en unknown
- 2014-10-23 EC ECIEPI201424082A patent/ECSP14024082A/es unknown
-
2015
- 2015-06-12 HK HK15105581.7A patent/HK1204869A1/xx unknown
-
2017
- 2017-02-21 US US15/438,223 patent/US20170157185A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
MY169754A (en) | 2019-05-15 |
PH12014502112A1 (en) | 2014-12-10 |
ECSP14024082A (es) | 2015-09-30 |
EP2827725A1 (en) | 2015-01-28 |
TWI587864B (zh) | 2017-06-21 |
AR090473A1 (es) | 2014-11-12 |
AU2013235365B2 (en) | 2016-05-19 |
AU2013235365A1 (en) | 2014-08-21 |
CN104219968A (zh) | 2014-12-17 |
HK1204869A1 (en) | 2015-12-11 |
CA2868109A1 (en) | 2013-09-26 |
US20130251829A1 (en) | 2013-09-26 |
RU2014137188A (ru) | 2016-05-20 |
NZ627915A (en) | 2016-07-29 |
CN108714157A (zh) | 2018-10-30 |
MX360591B (es) | 2018-11-09 |
MX2014010150A (es) | 2014-09-16 |
PE20142276A1 (es) | 2015-01-23 |
SG11201404378XA (en) | 2014-08-28 |
WO2013142403A1 (en) | 2013-09-26 |
TW201400124A (zh) | 2014-01-01 |
US20170157185A1 (en) | 2017-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO7151477A2 (es) | Material no viable derivado de un probiótico para la prevención y el tratamiento de la infección | |
MX2021006581A (es) | Bacterias modificadas para tratar enfermedades asociadas con hiperamonemia. | |
MY188541A (en) | Besifloxacin for the treatment of resistant acne | |
MX2017005252A (es) | Metodos para la preparacion de ribosidos. | |
MX2018006116A (es) | Materiales y metodos para el tratamiento de miopatias basadas en titina y otras titinopatias. | |
EP3912652C0 (en) | BACTERIAL NANOFIBRILLARY CELLULOSE BIO INK FOR THREE-DIMENSIONAL BIOPRINTING FOR CELL CULTIVATION, TISSUE GROWING AND REGENERATIVE MEDICINE APPLICATIONS | |
MX2017008720A (es) | Derivados y metodos para tratamiento de las infecciones por hepatitis b. | |
UY34201A (es) | Compuestos de azaindol y métodos para el tratamiento de vih. | |
EP3095855A4 (en) | Efficient bottom treatment bacillus, composite bottom treatment inoculant prepared using same and applications thereof | |
MX2017003797A (es) | Macrociclos peptidomimeticos y usos de los mismos. | |
IL254566A0 (en) | Textile engineered prosthetic devices, bioreactors and methods for producing textile engineered prosthetic devices | |
MX2015008703A (es) | Acido ribonucleico mensajero 124 como biomarcador. | |
EA030204B8 (ru) | Производные изоиндолина для применения в лечении вирусной инфекции | |
MX2017000142A (es) | Celulas estromales mesenquimatosas para tratar el sindrome de respuesta inflamatoria sistemica. | |
BR112017003705A2 (pt) | compostos contendo nitrogênio tricíclicos para o tratamento de infecção por neisseria gonorrhoea | |
MX2016009248A (es) | Compuestos que contienen nitrogeno y su uso como agentes antibacterianos. | |
EP3205713A4 (en) | Method for culturing 1,4-dioxane-decomposing bacteria, culture medium, and 1,4-dioxane treatment method using 1,4-dioxane-decomposing bacteria | |
EP2588121A4 (en) | C5A ANALOGUES AND METHODS OF USE THEREOF | |
EP3178899A4 (en) | Antifouling composition, treatment device, treatment method, and treated article | |
IN2014MU00916A (es) | ||
EP4226936A3 (en) | Non-neuroinvasive viruses and uses thereof | |
HUE058183T2 (hu) | Kórokozók inaktiválása biológiai közegben | |
HUE038826T2 (hu) | Berendezés fertõzõ, különösen orvosi hulladék kezelésére | |
PL3227239T3 (pl) | Sposób obróbki produktów odpadowych, w szczególności osadów z oczyszczania | |
FR3017550B1 (fr) | Machine de traitement de dechets infectieux, notamment medicaux |